Evidence map›Paper›PMID 34850113›Full record

ArticleNucleic acids research2021

MLL1 is regulated by KSHV LANA and is important for virus latency.

Min Tan, Shijun Li, Franceline Juillard, Rute Chitas, Tânia F Custódio, Han Xue, Agnieszka Szymula, Qiming Sun, Bing Liu, Ángel L Álvarez and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Min TanDepartments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Shijun LiDepartments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Franceline JuillardDepartments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Rute ChitasInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras 2780-157, Portugal.
Tânia F CustódioInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras 2780-157, Portugal.
Han XueState Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 200031 Shanghai, China.
Agnieszka SzymulaDepartments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Qiming SunDepartments of Biochemistry and Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
Bing LiuDepartments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Ángel L ÁlvarezDepartments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-9388-8595
She ChenProteomics Center, National Institute of Biological Sciences, Beijing 102206, China.ORCID 0000-0002-0830-3263
Jing HuangState Key Laboratory of Oncogenes and Related Genes, Shanghai Institute of Precision Medicine, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine 200125 Shanghai, China.ORCID 0000-0002-0481-8702
J Pedro SimasInstituto de Medicina Molecular, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.
Colin E McVeyInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras 2780-157, Portugal.
Kenneth M KayeDepartments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-5802-4556
Brigham and Women's Hospital · USUniversidade Nova de Lisboa · PTCenter for Excellence in Molecular Cell Science · CNNational Institute of Biological Sciences, Beijing · CNSecond Affiliated Hospital of Zhejiang University · CNShanghai Jiao Tong University · CNUniversidade Católica Portuguesa · PT

Funding

GENETIC AND BIOCHEMICAL STUDIES OF THE KSHV LANA GENER01CA082036 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI KAYE, KENNETH M · 1999 to 2019
$7.6M
KSHV Latent Infection ReplicationR01DE025208 · NIDCR · BRIGHAM AND WOMEN'S HOSPITAL · PI KAYE, KENNETH M · 2015 to 2025
$5.3M
Genetic and Biochemical Studies of KSHV LANAR01AI150575 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI KAYE, KENNETH M · 2020 to 2024
$3.4M
Platform technology for detection of cancer-associated viruses in HIV patientsR01DE024971 · NIDCR · STANFORD UNIVERSITY · PI DEMIRCI, UTKAN, KAYE, KENNETH M · 2015 to 2019
$2.1M
NCI NIH HHS R01 CA082036NIAID NIH HHS R01 AI150575NIDCR NIH HHS R01 DE024971NIDCR NIH HHS R01 DE025208
6 · The paper itself

Abstract

Mixed lineage leukemia 1 (MLL1) is a histone methyltransferase. Kaposi's sarcoma-associated herpesvirus (KSHV) is a leading cause of malignancy in AIDS. KSHV latently infects tumor cells and its genome is decorated with epigenetic marks. Here, we show that KSHV latency-associated nuclear antigen (LANA) recruits MLL1 to viral DNA where it establishes H3K4me3 modifications at the extensive KSHV terminal repeat elements during primary infection. LANA interacts with MLL1 complex members, including WDR5, integrates into the MLL1 complex, and regulates MLL1 activity. We describe the 1.5-Å crystal structure of N-terminal LANA peptide complexed with MLL1 complex member WDR5, which reveals a potential regulatory mechanism. Disruption of MLL1 expression rendered KSHV latency establishment highly deficient. This deficiency was rescued by MLL1 but not by catalytically inactive MLL1. Therefore, MLL1 is LANA regulable and exerts a central role in virus infection. These results suggest broad potential for MLL1 regulation, including by non-host factors.

Indexed as

Gene Expression Regulation, ViralAntigens, ViralCell Line, TumorCrystallography, X-RayDNA, ViralGene Knockdown TechniquesHerpesvirus 8, HumanHistone-Lysine N-MethyltransferaseHost-Pathogen InteractionsHumansIntracellular Signaling Peptides and ProteinsMyeloid-Lymphoid Leukemia ProteinNuclear ProteinsProtein BindingProtein ConformationSarcoma, KaposiAntigens, ViralDNA, ViralHistone-Lysine N-MethyltransferaseIntracellular Signaling Peptides and ProteinsKMT2A protein, humanlatency-associated nuclear antigenMyeloid-Lymphoid Leukemia ProteinNuclear ProteinsWDR5 protein, human

Identifiers

PMID34850113
PMCPMC8682764
OpenAlexW3215573579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.